Smith Group Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Smith Group Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-60	Closed	-$1K	–	405
2021 Q2	$1K	Hold	60	–	–	﹤0.01%	363
2021 Q1	$3K	Sell	60 -1,590	-96%	-$95.7K	﹤0.01%	322
2020 Q4	$102K	Hold	1,650	–	–	0.01%	205
2020 Q3	$90K	Buy	+1,650	New	+$88.8K	﹤0.01%	202
2019 Q3	–	Sell	-16,917	Closed	-$157K	–	458
2019 Q2	$157K	Sell	16,917 -4,700	-22%	-$54.4K	0.01%	217
2019 Q1	$300K	Sell	21,617 -1,280	-6%	-$14.6K	0.01%	199
2018 Q4	$250K	Sell	22,897 -3,550	-13%	-$37.4K	0.01%	226
2018 Q3	$334K	Hold	26,447	–	–	0.01%	215
2018 Q2	$348K	Hold	26,447	–	–	0.01%	211
2018 Q1	$360K	Sell	26,447 -923	-3%	-$9.52K	0.01%	210
2017 Q4	$163K	Hold	27,370	–	–	0.01%	267
2017 Q3	$203K	Sell	27,370 -2,000	-7%	-$16.6K	0.01%	266
2017 Q2	$275K	Sell	29,370 -13,380	-31%	-$98.2K	0.01%	254
2017 Q1	$311K	Hold	42,750	–	–	0.01%	225
2016 Q4	$316K	Buy	+42,750	New	+$308K	0.01%	218

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Smith Group Asset Management's CCXI Position: Q3 2021 in Review

Smith Group Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2021, closing a stake of 60 shares — an estimated $1K sold.

Smith Group Asset Management first reported a position in CCXI in Q4 2016 and held it in 15 quarters. The position peaked at $360K in Q1 2018. 140 funds tracked by Wall St. Rank hold CCXI as of Q3 2021.

Smith Group Asset Management reported no remaining ChemoCentryx, Inc. position as of Q3 2021 after selling out during the quarter.
Smith Group Asset Management sold 60 ChemoCentryx, Inc. shares in Q3 2021, an estimated $1K.
Smith Group Asset Management first reported a position in ChemoCentryx, Inc. in Q4 2016 and held it in 15 quarters.
Smith Group Asset Management's ChemoCentryx, Inc. position peaked at $360K in Q1 2018.
140 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2021.

Based on Smith Group Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.